Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

Back

ESC Professional Premium Access

Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

Session: Individual treatment strategies in atrial fibrillation

Topic: Diabetes and the Heart

Speaker: Professor G. Patti (Novara, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Giuseppe Patti

University of Eastern Piedmont, Novara (Italy)

4 presentations

2 followers

5 more presentations in this session

Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

Speaker: Doctor H. Ahn (Seoul, KR)

Preterm birth, abnormal foetal growth and the risk of atrial fibrillation later in life: a cohort study in Denmark, Finland and Sweden

Speaker: Miss F. Yang (Stockholm, SE)

The AFLETES study: atrial fibrillation in veteran athLETEs and the risk of stroke

Speaker: Doctor S. Pallikadavath (Leicester, GB)

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

Speaker: Doctor N. Bonini (Modena, IT)

The comorbidity network in older adults with atrial fibrillation: a danish nationwide cohort study

Speaker: Doctor L. Dai (Stockholm, SE)

Access the full session

Individual treatment strategies in atrial fibrillation

Speakers: Professor G. Patti, Doctor H. Ahn, Miss F. Yang, Doctor S. Pallikadavath, Doctor N. Bonini...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

29 August 2022

ESC Premium Access

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

29 August 2022

ESC Premium Access

Individual treatment strategies in atrial fibrillation

29 August 2022

ESC 365 is supported by

Explore sponsored resources

Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

About the speaker

Professor Giuseppe Patti

5 more presentations in this session

Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

Preterm birth, abnormal foetal growth and the risk of atrial fibrillation later in life: a cohort study in Denmark, Finland and Sweden

The AFLETES study: atrial fibrillation in veteran athLETEs and the risk of stroke

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

The comorbidity network in older adults with atrial fibrillation: a danish nationwide cohort study

Access the full session

Individual treatment strategies in atrial fibrillation

About the event

ESC Congress 2022

Related content

Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

Individual treatment strategies in atrial fibrillation

ESC 365 is supported by